![Garratt W. Ponder](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Garratt W. Ponder
Företagsledare/Principal på
Tikvah Therapeutics, Inc.
Profil
Garratt W.
Ponder is Vice President of Pharmaceutical Development for Tikvah Therapeutics, Inc. Prior to joining Tikvah Therapeutics, he was Senior Director of Product Development for AtheroGenics, Inc. Before joining AtheroGenics in 2003, he worked at Endeavor Pharmaceuticals, Inc. and Solvay Pharmaceuticals, Inc. He has over 12 years of experience in analytical chemistry, process chemistry, and pharmaceutical development.
Dr. Ponder received a BS degree in Chemistry in 1989 and a PhD in Pharmaceutical Analysis from the University of Georgia in 1995.
Aktiva positioner av Garratt W. Ponder
| Företag | Position | Start |
|---|---|---|
Tikvah Therapeutics, Inc.
 Tikvah Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops novel therapeutic products | Företagsledare/Principal | - |
Tidigare kända positioner av Garratt W. Ponder
| Företag | Position | Slut |
|---|---|---|
Endeavor Pharmaceuticals, Inc.
 Endeavor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures hormone replacement pharmaceutical products | Företagsledare/Principal | - |
Solvay Pharmaceuticals, Inc.
 Solvay Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Företagsledare/Principal | - |
AtheroGenics, Inc.
 AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel drugs for the treatment of chronic inflammatory diseases | Företagsledare/Principal | - |
Garratt W. Ponders utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
93
Första gradens relationer
5
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
AtheroGenics, Inc.
AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel drugs for the treatment of chronic inflammatory diseases | Health Technology |
Endeavor Pharmaceuticals, Inc.
Endeavor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures hormone replacement pharmaceutical products | Health Technology |
Tikvah Therapeutics, Inc.
Tikvah Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops novel therapeutic products | Health Technology |
Solvay Pharmaceuticals, Inc.
Solvay Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
University of Georgia
 University of Georgia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
